Works matching AU Ranjan, Mukesh

Results: 37
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Intravenous Albumin Infusion Does not Augment the Response Rate to a Combination of Exclusive Enteral Nutrition and Intravenous Steroids in Acute Severe Ulcerative Colitis: A Randomised Controlled Trial.

    Published in:
    Journal of Crohn's & Colitis, 2024, v. 18, n. 11, p. 1870, doi. 10.1093/ecco-jcc/jjae094
    By:
    • Mundhra, Sandeep K;
    • Madan, Divya;
    • Golla, Rithvik;
    • Sahu, Pabitra;
    • Vuyyuru, Sudheer K;
    • Kante, Bhaskar;
    • Kumar, Peeyush;
    • Thomas, David Mathew;
    • Prasad, Shubham;
    • Vaishnav, Manas;
    • Verma, Mahak;
    • Virmani, Shubi;
    • Bajaj, Aditya;
    • Markandey, Manasvani;
    • Ranjan, Mukesh Kumar;
    • Arora, Umang;
    • Singh, Mukesh Kumar;
    • Makharia, Govind K;
    • Ahuja, Vineet;
    • Kedia, Saurabh
    Publication type:
    Article
    18

    Thiopurines Have Sustained Long-term Effectiveness in Patients with Inflammatory Bowel Disease, Which is Independent of Disease Duration at Initiation: A Propensity Score Matched Analysis.

    Published in:
    Journal of Crohn's & Colitis, 2024, v. 18, n. 2, p. 192, doi. 10.1093/ecco-jcc/jjad135
    By:
    • Ranjan, Mukesh Kumar;
    • Kumar, Peeyush;
    • Vuyyuru, Sudheer Kumar;
    • Kante, Bhaskar;
    • Mundhra, Sandeep K;
    • Golla, Rithvik;
    • Virmani, Shubi;
    • Sharma, Raju;
    • Sahni, Peush;
    • Das, Prasenjit;
    • Kalaivani, Mani;
    • Upadhyay, Ashish Datt;
    • Makharia, Govind;
    • Kedia, Saurabh;
    • Ahuja, Vineet
    Publication type:
    Article
    19
    20
    21

    Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring.

    Published in:
    Intestinal Research, 2023, v. 21, n. 4, p. 460, doi. 10.5217/ir.2022.00128
    By:
    • Kumar, Peeyush;
    • Vuyyuru, Sudheer K.;
    • Das, Prasenjit;
    • Kante, Bhaskar;
    • Ranjan, Mukesh Kumar;
    • Thomas, David Mathew;
    • Mundhra, Sandeep;
    • Sahu, Pabitra;
    • Venigalla, Pratap Mouli;
    • Jain, Saransh;
    • Goyal, Sandeep;
    • Golla, Rithvik;
    • Virmani, Shubi;
    • Singh, Mukesh K.;
    • Sachdeva, Karan;
    • Sharma, Raju;
    • Dash, Nihar Ranjan;
    • Makharia, Govind;
    • Kedia, Saurabh;
    • Ahuja, Vineet
    Publication type:
    Article
    22
    23
    24

    Use of thiopurines in inflammatory bowel disease: an update.

    Published in:
    Intestinal Research, 2022, v. 20, n. 1, p. 11, doi. 10.5217/ir.2020.00155
    By:
    • Singh, Arshdeep;
    • Mahajan, Ramit;
    • Kedia, Saurabh;
    • Dutta, Amit Kumar;
    • Anand, Abhinav;
    • Bernstein, Charles N.;
    • Desai, Devendra;
    • Pai, C. Ganesh;
    • Makharia, Govind;
    • Tevethia, Harsh Vardhan;
    • Mak, Joyce W. Y.;
    • Kaur, Kirandeep;
    • Peddi, Kiran;
    • Ranjan, Mukesh Kumar;
    • Arkkila, Perttu;
    • Kochhar, Rakesh;
    • Banerjee, Rupa;
    • Sinha, Saroj Kant;
    • Siew Chien Ng;
    • Hanauer, Stephen
    Publication type:
    Article
    25
    26
    27
    28

    Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti‐TNF therapy in tuberculosis endemic region.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 11, p. 1431, doi. 10.1111/apt.16839
    By:
    • Kumar, Peeyush;
    • Vuyyuru, Sudheer K.;
    • Kante, Bhaskar;
    • Sahu, Pabitra;
    • Goyal, Sandeep;
    • Madhu, Deepak;
    • Jain, Saransh;
    • Ranjan, Mukesh Kumar;
    • Mundhra, Sandeep;
    • Golla, Rithvik;
    • Singh, Mukesh;
    • Virmani, Shubi;
    • Gupta, Anvita;
    • Yadav, Nidhi;
    • Kalaivani, Mani;
    • Sharma, Raju;
    • Das, Prasenjit;
    • Makharia, Govind;
    • Kedia, Saurabh;
    • Ahuja, Vineet
    Publication type:
    Article
    29

    Randomised clinical trial: exclusive enteral nutrition versus standard of care for acute severe ulcerative colitis.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 5, p. 568, doi. 10.1111/apt.16249
    By:
    • Sahu, Pabitra;
    • Kedia, Saurabh;
    • Vuyyuru, Sudheer K.;
    • Bajaj, Aditya;
    • Markandey, Manasvini;
    • Singh, Namrata;
    • Singh, Mukesh;
    • Kante, Bhaskar;
    • Kumar, Peeyush;
    • Ranjan, Mukesh;
    • Sahni, Peush;
    • Panwar, Rajesh;
    • Sharma, Raju;
    • Das, Prasenjit;
    • Makharia, Govind;
    • Travis, Simon P. L.;
    • Ahuja, Vineet
    Publication type:
    Article
    30
    31
    32
    33

    Minimal risk of lymphoma and non‐melanoma skin cancer despite long‐term use of thiopurines in patients with inflammatory bowel disease: A longitudinal cohort analysis from northern India.

    Published in:
    Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 8, p. 1544, doi. 10.1111/jgh.15880
    By:
    • Ranjan, Mukesh Kumar;
    • Kante, Bhaskar;
    • Vuyyuru, Sudheer Kumar;
    • Kumar, Peeyush;
    • Mundhra, Sandeep K;
    • Golla, Rithvik;
    • Sharma, Raju;
    • Sahni, Peush;
    • Das, Prasenjit;
    • Makharia, Govind;
    • Kedia, Saurabh;
    • Ahuja, Vineet
    Publication type:
    Article
    34
    35
    36
    37